While Over Three-Quarters of Americans Are Willing to Take at Least One of the Authorized COVID-19 Vaccines, Nearly a Quarter Are Still Hesitant as the U.S. Changes Course on Mitigation Strategy
New Informa Pharma Intelligence report shows that while vaccine hesitancy creates an uphill battle for